Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure and Iron Deficiency in Romania

Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure and Iron Deficiency in Romania

Background: Ferric carboxymaltose (FCM) treatment in case of iron deficient (ID) patients with chronic heart failure (CHF) has shown great promise according to the findings of recent studies in improvement of symptoms and quality of life, New York Heart Association (NYHA) classification, and exercis...

Full description

Bibliographic Details
Main Authors: Lorenzovici László, Székely Andrea, Farkas-Ráduly Szabolcs, Jitaru Ciprian, Csanádi Marcell
Format: Article
Language:English
Published: Sciendo 2019-12-01
Series:Journal of Cardiovascular Emergencies
Subjects:
heart failure
iron deficiency
treatment cost
budget impact
ferric carboxymaltose
romania
Online Access:https://doi.org/10.2478/jce-2019-0018

Internet

https://doi.org/10.2478/jce-2019-0018

Similar Items